Kyowa Kirin Co., Ltd.

4151.T
Drug Manufacturers - Specialty & Generic
2026/08/03 Updated
Market Cap: $8.5B (¥1.3T)
Stock Price: $16.17 (¥2,555)
Exchange Rate: 1 USD = ¥157.98

Kowa Kirin Co., Ltd. 2026 Fiscal Year December Interim (Six-Month) Financial Summary [IFRS] (Consolidated)

The consolidated results for the second half of the 2026 fiscal year (six months) disclose trends in revenue and profit. The financial position including changes in non-current and current assets, liabilities, and capital structure is reported, along with regional revenue composition, segment revenue mix, and cash flow status.

Importance:
Page Updated: August 3, 2026
IR Disclosure Date: August 3, 2026

Key Figures

  • Revenue: 2,636,000 million yen (YoY +14.3%)
  • Core operating profit: 661 million yen (YoY increase)
  • Interim profit: 306 million yen (YoY increase)
  • Total assets: 1,130,944 million yen
  • Shareholders' equity: 916,165 million yen

AI要約

Section Heading

This financial summary provides a concise view of the consolidated financial position and performance for the interim period of the 2026 fiscal year. It explains the overall financial condition, including asset, liability, and capital structure, cash flow outline, regional revenue composition, and segment-level revenue mix. It highlights the trends in revenue and core operating profit, as well as the factors behind changes in interim net income, with accompanying graphs and notes.

Section 2 Heading

As indicators of capital policy and financial soundness, this section describes asset and liability structure, the impact of equity-method accounting, movements in shareholders' equity, and the ending balance of cash and cash equivalents. It also presents revenue composition by regional holding company and by product, including notes that hint at future growth drivers.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kowa Kirin Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →